10-Q: Elite Health Systems Q1 2026 Results Show Significant Net Loss

Elite Health Systems Inc. reported a substantial net loss for the first quarter of 2026, primarily driven by the acquisition of Physician Support Systems (PSS) and the commencement of operations for its Medicare Advantage plans.

Summary

• Elite Health Systems Inc. reported a net loss of $1,294,000 for the three months ended March 31, 2026, a significant increase from the $424,000 net loss in the same period of 2025.
• Revenue for the first quarter of 2026 was $1,398,000, compared to no revenue in the first quarter of 2025.
• Selling, general, and administrative expenses increased to $1,415,000 in Q1 2026 from $427,000 in Q1 2025, largely due to the acquisition of PSS and increased costs at Elite Health Plan (EHP) now that it is operational.
• The company's cash and cash equivalents decreased to $2,602,000 as of March 31, 2026, from $3,758,000 as of December 31, 2025.
• The company has an accumulated deficit of $13,543,000 as of March 31, 2026.
• Management has raised substantial doubt regarding the company's ability to continue as a going concern, but believes its plans will alleviate this doubt.
• The company acquired Physician Support Systems (PSS) in November 2025, which contributed to the financial results and is expected to strengthen the company's financial statements and market recognition.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to the significant increase in net loss, rising expenses, and ongoing going concern issues, despite the commencement of revenue generation.

Positives

• Generated $1,398,000 in revenue in Q1 2026, a significant increase from zero revenue in Q1 2025, indicating the start of revenue generation from its Medicare Advantage plans.
• Acquisition of Physician Support Systems (PSS) is expected to strengthen the company's health experience, provider access, and management team.
• PSS is an operating business with revenue, contributing to stronger financial statements.
• The combined entity is expected to have greater access to capital and market recognition.
• The acquisition is expected to be viewed positively by regulators and the healthcare market.
• Elite Health Plan received Knox-Keene license approval in California and CMS approval in 2025, and began operating its Medicare Advantage plan in January 2026.

Negatives

• Reported a net loss of $1,294,000 for Q1 2026, compared to a net loss of $424,000 in Q1 2025.
• Selling, general, and administrative expenses increased significantly to $1,415,000 in Q1 2026 from $427,000 in Q1 2025.
• Cash and cash equivalents decreased from $3,758,000 at the end of 2025 to $2,602,000 at the end of Q1 2026.
• The company has an accumulated deficit of $13,543,000 as of March 31, 2026.
• The company has no access to a line of credit or other readily available sources of capital, raising substantial doubt about its ability to continue as a going concern.
• The company recorded a goodwill impairment charge of $3,978,000 at December 31, 2025, related to the PSS acquisition.
• CB Oncology Partners (CBOP) continues to incur losses, with EHSHI's equity in loss being $80,000 in Q1 2026.

Risks

• Uncertainty regarding the ability to successfully implement the strategy of developing a Medicare Advantage plan.
• Uncertainty over the ability to achieve a Medicare Advantage license in California in a timely manner, acquire managed health consumers, expand enrollment beyond the initial state, or diversify the product portfolio, which could significantly impair business and operations.
• The company's ability to raise capital in the future on satisfactory terms.
• The company's financial condition and liquidity.
• Uncertainty over the ability to successfully implement management's plan to improve liquidity, including managing costs, systems, and growth.
• The company's Medicare Advantage plan license is subject to attestations and audits, with no assurance of maintenance.
• There can be no assurance that sources of capital will be available or obtainable on favorable terms.
• The company is subject to lawsuits, investigations, and potential claims arising from its ordinary business conduct, although no material litigation is currently pending.

Future Outlook

The company is focused on the establishment and operation of managed health care plans, specifically its Medicare Advantage plans. Management believes its plans will alleviate the substantial doubt regarding its ability to continue as a going concern and that it will be successful in its planned business initiatives and able to continue as a going concern through at least the next twelve months. However, there is no assurance that sources of capital will be available or obtainable on favorable terms.

Management Comments

• Management believes its plan alleviates the substantial doubt regarding the company's ability to continue as a going concern and that it will be successful in its planned business initiatives and will be able to continue as a going concern through at least the next twelve months.
• Management has considered its plans to continue the Company as a going concern, concentrating on the establishment and operation of managed health care plans.
• The Company is evaluating different approaches to raise the capital that it will require, as well as other strategic options to support operations.

Industry Context

StockSavvy.ai notes that Elite Health Systems Inc. is operating in the highly competitive and regulated Medicare Advantage market. The company's recent operational launch and acquisition of PSS indicate a strategic push to build scale and service capabilities. However, the significant net loss and going concern doubts highlight the substantial capital requirements and execution risks inherent in this sector, particularly for newer entrants.

Comparison to Industry Standards

• The company's revenue of $1.398 million in Q1 2026 is a starting point, but significantly lower than established Medicare Advantage providers like UnitedHealth Group (Optum) or Humana, which generate billions in quarterly revenue.
• The net loss of $1.294 million in Q1 2026, while substantial for Elite Health Systems, is a common occurrence for companies launching new health plans or expanding into new markets, as significant upfront investment in network development, technology, and member acquisition is required.
• The company's cash balance of $2.6 million is modest compared to larger healthcare companies. For instance, Centene Corporation reported over $3 billion in cash and cash equivalents as of Q1 2026 (hypothetical comparison).
• The accumulated deficit of $13.5 million reflects the early-stage nature of the business and the capital-intensive path to profitability in the managed care industry.

Legal Proceedings

• The Company is subject to lawsuits, investigations and potential claims arising out of the ordinary conduct of its business.
• The Company is not currently involved in any material litigation.

Related Party Transactions

• Revenue associated with PSS of $1,398,000 for the quarter ended March 31, 2026, comes from related parties, as Dr. Jeereddi was the majority owner of PSS and Ms. Reeher was the Executive Director.
• During the year ended December 31, 2025, and the quarter ended March 31, 2026, the Company compensated PSS for services of Ms. Reeher and others, as well as for the sharing of rental space and other services.
• Each of the customers of PSS are companies with either a familial and or management relationship to Dr. Jeereddi.

Stakeholder Impact

• Shareholders: Facing continued dilution from capital raises and significant accumulated losses, with ongoing uncertainty about the company's ability to continue as a going concern.
• Employees: Potential impact from the company's financial instability and the need for future capital raises, which could affect job security or growth opportunities.
• Creditors: The company's lack of readily available capital and going concern issues may impact its ability to meet its financial obligations.
• Regulators: The company's operational launch and acquisition are positive steps, but continued financial scrutiny and the need to maintain licenses will be critical.

Next Steps

• Continue to establish and operate managed health care plans, specifically Medicare Advantage plans.
• Evaluate different approaches to raise required capital.
• Explore other strategic options to support operations.
• Continue to onboard members for its Medicare Advantage Plans in California.
• Potentially expand types of plans to include special needs plans.
• Ultimately expect to apply to the State of Nevada and other states for licenses.

Key Dates

Recommendation

The company has begun generating revenue and has made strategic acquisitions, but the significant net loss, substantial accumulated deficit, and ongoing going concern issues present considerable risk. The need for further capital raises and the uncertainty of future funding warrant a cautious 'hold' recommendation until a clearer path to profitability and sustainable operations is demonstrated.

Keywords

Elite Health Systems, Form 10-Q, Medicare Advantage, Healthcare, Financial Report, Quarterly Results, Physician Support Systems, Going Concern, Capital Raise, SEC Filing